SPDR S&P Pharmaceuticals ETF
XPH
XPH
73 hedge funds and large institutions have $117M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $109M → $117M (+$7.69M)
15.11% less ownership
Funds ownership: 60.76% → 45.65% (-15%)
Holders
73
Holding in Top 10
–
Calls
$3.33M
Puts
$335K
Top Buyers
| 1 | +$3.74M | |
| 2 | +$1.74M | |
| 3 | +$1.4M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.19M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.15M |
Top Sellers
| 1 | -$16.1M | |
| 2 | -$7.61M | |
| 3 | -$1.03M | |
| 4 |
BCM
Brookstone Capital Management
Wheaton,
Illinois
|
-$768K |
| 5 |
Goldman Sachs
New York
|
-$676K |